IND-enabling phase

Dialectic

Dialectic Therapeutics Plans to Further Cancer Drug Research Using $3M Seed Award

by | Feb 26, 2020
Using innovative new technologies and targeted therapies, the Dallas biotech startup aims to help patients with cancer, give them hope, and prolong their lives.
MORE